COVID-19, FDA and Vaccine
Digest more
A group of experts who advise the US Food and Drug Administration on its vaccine decisions voted unanimously Thursday to make a broad recommendation about which lineage of the coronavirus should be included in this year’s Covid-19 vaccines,
See what infectious disease doctors have to say as government officials appear poised to scale back COVID vaccines and the FDA approved the Novavax vaccine with new limitations.
The change marks a shift in the Food and Drug Administration’s policy on approving COVID-19 vaccines, which the new commissioner described as a “one-size-fits-all regulatory framework.”
The US Food and Drug Administration is changing the way it approves Covid-19 vaccines for Americans, a move that may limit future shots to older Americans and people at higher risk of serious Covid-19 infection.
Secretary Kennedy's appointment led to fears that vaccine availability would be curtailed. Those fears are now being realized.